FDA Approves B. Braun’s Nutrilipid For Parenteral Nutrition Therapy

B. Braun Medical Inc. Aug. 13 announced that the Food and Drug Administration has approved Nutrilipid 20 percent (I.V. fat emulsion) for parenteral nutrition therapy in adult and pediatric patients.

Nutrilipid 20 percent is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition isn’t possible, insufficient or contraindicated, the company said. The product will be available in flexible containers that aren’t made with DEHP, PVC or natural rubber latex.

B. Braun said the approval of Nutrilipid 20 percent will ...